- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02361606
An Internet Cognitive-Behavioral Intervention for Youth With Type 1 Diabetes - Participation and Efficacy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Adolescents are often reluctant to receive psychological help. The investigators developed a web-based cognitive behavioral self-help intervention for adolescents with type 1 diabetes. The investigators aimed to examine the participation rate and outcomes on glycemic control and quality of life.
Single center study was conducted to describe participation and efficacy of internet cognitive-behavioral intervention for youth with type 1 diabetes. Adolescents with type 1 diabetes, aged 13-20 years, treated at a Juvenile Diabetes Center, were offered to participate in the intervention. Recruitment period lasted for 2 months, during January-February, 2011.
HbA1c measures of adolescents that agreed to participate, were obtained from medical records.The adolescents, that logged in, were asked to complete questionnaires before the intervention assessing their expectations of the program, quality of life and parental support. After completion of questionnaires, the adolescents were encouraged to complete 6 virtual sessions. Satisfaction was assessed after each session. In the end of the program, participants were asked again to complete questionnaires. HbA1c levels were obtained again for participants that logged in, and for participants that passively refused, 3 months or more after the recruitment.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- diagnosis with diabetes for at least 1 year
- treated at Juvenile Diabetes Center
- fluent Hebrew speakers
Exclusion Criteria:
- no previous diagnosis of a psychiatric condition (such as an eating disorder)
- no opposition to the internet due to religious issues.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Internet CBT intervention
Eligible candidates were offered to participate in an internet cognitive behavioral intervention.
|
We developed a cognitive behavioral program for adolescents with type 1 Diabetes and their parents, that consists of six virtual sessions at https://minustress.com/diabetes/gate.asp.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in quality of life. (Diabetes Quality of Life (DQOL) questionnaire)
Time Frame: Change from baseline to the end of intervention (3 to 6 months from baseline)
|
Filled in the intervention website.
|
Change from baseline to the end of intervention (3 to 6 months from baseline)
|
|
Perceived parent support. (Short version of the Social Provision Scale)
Time Frame: Change from baseline to the end of intervention (3 to 6 monts)
|
Short version of the Social Provision Scale -filled in the intervention website.
|
Change from baseline to the end of intervention (3 to 6 monts)
|
|
Youth satisfaction of the program. (Questionnaire regarding the degree that the session was helpful.)
Time Frame: Measured at the end of every virtual session (2 days to 6 months from baseline).
|
Questionnaire regarding the degree that the session was helpful.
|
Measured at the end of every virtual session (2 days to 6 months from baseline).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in glycemic control. (HbaA1c levels, obtained from medical records)
Time Frame: Last HbA1C before recruitment period and first HbA1C after recruitment period were obtained from medical records (3-12 months from baseline).
|
HbaA1c levels, obtained from medical records twice - the closest measurement available before the trial period, and closest measurement available 3 months or more after the trial period.
|
Last HbA1C before recruitment period and first HbA1C after recruitment period were obtained from medical records (3-12 months from baseline).
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Youth expectations of the program. (Questionnaire regarding the expectations of the possible benefits of the program.)
Time Frame: Baseline
|
Questionnaire regarding the expectations of the possible benefits of the program.
|
Baseline
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Orit Pinhas Hamiel, MD, Sheba Medical Center
- Study Director: Daniel Hamiel, PhD, The Interdisciplinary Center
- Principal Investigator: Irena Vusiker, MA, Sheba Medical Center
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2009108
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 1 Diabetes
-
COUR Pharmaceutical Development Company, Inc.RecruitingType 1 Diabetes | Type 1 Diabetes Mellitus | T1DM | T1D | Type 1 Diabetes in Adolescence | Type 1 Diabetes in Children | Type 1 Diabetes Patients | Type 1 Diabetes Mellitis | T1DM - Type 1 Diabetes Mellitus | Type 1 Diabetes (Juvenile Onset)United States
-
Lund UniversityEnrolling by invitationType 1 Diabetes Mellitus | Stage 2 Type 1 Diabetes | Stage 1 Type 1 Diabetes | Stage 3 Type 1 DiabetesSweden
-
Immunocore LtdNot yet recruitingType 1 Diabetes | Diabetes Type 1 | Type 1 Diabetes (T1D)
-
Sultan Qaboos UniversityUniversity of Mosul; University of Child Health Sciences and Children's Hospital...Not yet recruitingType 1 Diabetes Mellitus | T1DM | Type 1 Diabetes Mellitus (T1DM) | T1DM - Type 1 Diabetes Mellitus
-
GentiBio, IncRecruitingType 1 Diabetes Mellitus | Type 1 Diabetes (T1D)United States
-
Stanford UniversityUniversity College Dublin; The Leona M. and Harry B. Helmsley Charitable TrustNot yet recruitingType 1 Diabetes (T1D) | Type 1 Diabetes Mellitus (T1DM) | Exercise Physiology | Type 1 Diabetes MellitisUnited States
-
Dasman Diabetes InstituteRecruitingType 1 Diabetes (T1D) | Type 1 Diabetes Mellitus (T1DM)Kuwait
-
Superior UniversityActive, not recruitingType 2 Diabetes Mellitus 1Pakistan
-
Insulet CorporationNot yet recruitingType 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes (DM)New Zealand
-
Poznan University of Medical SciencesUnknownDiabetes Mellitus Type 1 | Remission of Type 1 Diabetes | Chronic Complications of DiabetesPoland
Clinical Trials on An Internet Cognitive-Behavioral Intervention
-
University of Southern DenmarkNot yet recruitingAlcohol Use Disorder (AUD)
-
Karolinska InstitutetRecruitingDepression | Anxiety Disorders | Insomnia | Psychiatric DisorderSweden
-
Mclean HospitalCompletedMajor Depressive DisorderUnited States
-
The Miriam HospitalNational Institute of Allergy and Infectious Diseases (NIAID); Brown UniversityCompletedObesity | Overweight | HIV
-
Karolinska InstitutetCompletedObsessive-compulsive DisorderSweden
-
Karolinska InstitutetVastra Gotaland Region; Region StockholmCompleted
-
University of TromsoUnknownComplicated Grief
-
Lund UniversityRecruitingGeneralized Anxiety Disorder | Social Anxiety Disorder | Panic Disorder | Separation Anxiety Disorder | Specific Phobia | Agoraphobia | ANXIETY DISORDERS (or Anxiety and Phobic Neuroses)Sweden
-
Karolinska InstitutetUppsala UniversityRecruiting
-
Montefiore Medical CenterNational Center for Advancing Translational Sciences (NCATS)WithdrawnInflammatory Bowel Diseases | Psychological DistressUnited States